Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-05-10 @ 4:14 PM
Study NCT ID:
NCT06141460
Status:
RECRUITING
Last Update Posted:
2024-11-14
First Post:
2023-11-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
Sponsor:
Shanghai Refreshgene Technology Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RRG001-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None